LLY — Eli Lilly and Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Eli Lilly and Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	fx Preliminary
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3,909	2,212	2,928	3,423	—
Net Total Accounts Receivable
Net Total Receivables	8,127	8,559	11,336	13,275	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	18,452	18,035	25,727	32,740	—
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8,985	10,144	12,914	17,102	—
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	48,806	49,490	64,006	78,715	—
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15,053	17,138	27,293	28,377	—
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	39,827	38,840	53,234	64,523	—
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	8,979	10,650	10,772	14,192	—
Total Liabilities & Shareholders' Equity	48,806	49,490	64,006	78,715	—
Total Common Shares Outstanding